Tonix prices 615,025 shares at $16.26 in registered direct offering

Group 1 - Tonix Pharmaceuticals (TNXP) has entered into a securities purchase agreement with Point72 for the purchase and sale of 615,025 shares of its common stock at an offering price of $16.26 per share [1] - In addition to common stock, the agreement includes pre-funded warrants to purchase up to an aggregate of 615,025 shares of common stock at a purchase price of $16.259 per pre-funded warrant [1] - The gross proceeds of the offering are expected to be approximately $20 million before deducting placement agent fees and other estimated offering expenses [1] Group 2 - The closing of the offering is anticipated to occur on or about December 30, subject to customary closing conditions [1] - TD Cowen is acting as the sole placement agent for the offering, while A.G.P./Alliance Global Partners is serving as a financial advisor [1]